Comparative efficacy of carfilzomib, lenalidomide, and dexamethasone (<scp>KRd</scp>) versus bortezomib, lenalidomide, and dexamethasone (<scp>VRd</scp>) in newly‐diagnosed multiple myeloma: A systematic review and meta‐analysis

Authors:

Published: 0000-00-00

DOI: HTTPS://DOI.ORG/10.1002/ajh.27314

Keywords:

Abstract:

Source: